RNA circularization strategies in vivo and in vitro.

Petkovic S, Müller S. · 2015

Read RNA circularization strategies in vivo and in vitro. by Petkovic S, Müller S. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4344496.txt.

Introduction

Sonja Petkovic and Sabine Müller review circular RNAs and how to make them. Their review appeared in Nucleic Acids Research in 2015. Ring shaped RNAs occur in every domain of life: cells, archaea, bacteria, and viruses. Their roles were underestimated for years. One reason is that the ring has no ends for standard tools to grab.

Some rings serve in virus and viroid life cycles or in maturing transfer RNAs. Because exonuclease enzymes cannot chew them from an end, lab made rings are attractive as durable tools: aptamers, ribozymes, and silencing RNAs that survive in cells. The review explains how nature closes the ring and gives practical protocols for closing it in the test tube.

Catalog record

CREATORPetkovic S, Müller S.
YEAR2015
COLLECTIONPAPERS
FORMATTXT
FILE SIZE61 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4344496

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

RNA circularization strategies in vivo and in vitro By Sonja Petkovic, Sabine Müller Published in: Nucleic Acids Research DOI: 10.1093/nar/gkv045 ABSTRACT In the plenitude of naturally occurring RNAs, circular RNAs (circRNAs) and their biological role were underestimated for years. However, circRNAs are ubiquitous in all domains of life, including eukaryotes, archaea, bacteria and viruses, where they can fulfill diverse biological functions. Some of those functions, as for example playing a role in the life cycle of viral and viroid genomes or in the maturation of tRNA genes, have been elucidated; other putative functions still remain elusive. Due to the resistance to exonucleases, circRNAs are promising tools for in vivo application as aptamers, trans-cleaving ribozymes or siRNAs. How are circRNAs generated in vivo and what approaches do exist to produce ring-shaped RNAs in vitro? In this review we illustrate the occurrence and mechanisms of RNA circularization in vivo, survey methods for the generation of circRNA in vitro and provide appropriate protocols. INTRODUCTION Circular RNAs are found in all kingdoms of life, appearing for example as genomes of viroidal plant pathogens (1) and of the hepatitis delta virus (HDV) (2), or as spliced tRNA and rRNA introns and as rRNA processing intermediates in archaea (3,4). Furthermore, circRNAs are formed in the life cycle of bacterial and eukaryal group I introns, where they were suggested to play a role in intron mobility by reverse splicing (5–7). However, circRNAs were considered extremely rare in nature for decades, and in particular in eukaryotes, circRNAs were seen as minor RNA structural variants attributed to transcriptional noise (8). This view has dramatically changed, as a number of recent reports have convincingly demonstrated that circRNAs in eukaryotes are highly abundant and evolutionary conserved. Apparently, thousands of human transcripts are expressed as circular isoforms of their linear counterparts (9–13). The functions of circRNAs in eukaryotes still remain more or less elusive, although it has been suggested that circRNAs may act as transcription regulators (10) or as competing endogenous RNAs to bind miRNAs (RNA sponges) or RNA binding proteins (protein sponges), and thus to modulate their local free concentration (11–15). Moreover, it was suggested that circRNAs might encode proteins with functions distinct from those of their canonical linear counterparts. At least in vitro translation of circRNAs was demonstrated (16). Very interestingly, circRNAs were described as biomarkers of aging in Drosophila (17) and as putative disease biomarkers in human saliva (18). However, the large number of detected circRNAs is also critically discussed. There is some agreement that artifacts of RT-PCR detection may add to the large number of circRNAs. A recent report raises serious doubts regarding the biological function of most circRNAs. Based on the results of a computational approach for identification and analysis of circRNAs, the authors suggest that apart from CDR1as, which indeed appears to function as miR-7 sponge (11,12), a large majority of circRNAs might be just inconsequential side products of pre-mRNA splicing (13). Nevertheless, as mentioned above, there is also good agreement that circRNAs may fulfill important functions, although not much is known yet. What might be the advantage of RNA being in a circular form rather than in the traditional linear one? The most obvious reason is certainly stability. Since exonucleases are ubiquitously spread, circRNAs are advantageous in terms of being protected against degradation. The covalently closed ring structure may be not only favorable for endogenous RNAs, but should also be beneficial to the application of RNAs for example as antisense-RNAs, aptamers, ribozymes or siRNAs (19–23). What are the strategies for production of circRNAs? In vivo, circRNAs usually result from splicing events, either as exonic circRNA from circularization of exons or as intronic circRNA, such as, for example, circular tRNA and rRNA introns produced from archaeal splicing. Circular RNAs appear in viruses and viroids and as viroid-like satellite RNAs. In vitro, RNA circularization involves the intramolecular formation of a 3′, 5′-phosphodiester bond, requiring close proximity of the 3′- and 5′-terminus of the linear precursor. Here we review pathways of circRNA formation in vivo and strategies for RNA circularization in vitro. Furthermore, we provide a collection of protocols to be used for the purpose of RNA circularization (Supplementary data). CIRCULARIZATION IN VIVO Formation of exonic circRNAs In eukaryotic cells the spliceosome acts to remove introns from primary transcripts in a two-step mechanism. In the first step, the 2′-OH group of a defined adenosine within the intron (branch point adenosine) attacks the 5′-splice site, generating a free 3′-OH group at the 5′-exon and the lariat intermediate. The second step involves nucleophilic attack of the generated 3′-OH group onto the 3′-splice site, producing the final products: an excised lariat intron and a linear RNA composed of the two combined exons (Figure 1a). [Figure: Regular linear splicing (a) and two models for the formation of exonic circRNAs (b, c). (a) Upon folding, the branch point adenosine (bpA) attacks the 5′- splice site, delivering the 5′-exon with free 3′-OH group and the lariat intermediate with the intron still linked to the 3′-exon. Nucleophilic attack of the 3′-OH group of the 5′-exon onto the 3′-splice site leads to ligation of the two exons, and to release of the intron as lariat. (b) Direct backsplicing. Two unspliced introns interact by complementary base pairing, thereby juxtaposing the branch point of the 5′-intron and the 3′-intron–exon junction (3′-splice donor) for nucleophilic attack and cleavage. Then, the 3′-splice donor attacks the 5′-intron–exon junction (5′-splice acceptor) joining the two introns and releasing the circularized exon. (c) Exon skipping. Through skipping of an exon, an exon containing lariat is created following the normal mechanism of splicing. Backsplicing then occurs as described above, but within the lariat. As a result, the intron lariat is released and a circular RNA is produced.] In addition, exonic circRNAs may result from spliceosomal action. They were first observed in 1991 (24). Since then, thousands of endogenous circRNAs have been identified in mammalian cells, some of them highly abundant and evolutionary conserved (for recent reviews see (25–27)). The detailed mechanism of circRNA biogenesis has remained elusive. Currently, two major mechanisms involving the canonical spliceosome are discussed: (i) direct backsplicing and (ii) exon skipping (Figure 1b and c). What is referred to as ‘direct backsplicing’ (25) was historically termed ‘mis-splicing’ by exon shuffling or exon scrambling, where exons are spliced in non-canonical order (8). However, taking into account that circRNAs may be generated by purpose rather than resulting from mis-splicing events, ‘backsplicing’ is a more appropriate name. Mechanistically, ‘direct backsplicing’ involves joining of the 3′-tail of an expected downstream exon to the 5′-head of an exon that is normally upstream. The downstream splice donor pairs with an unspliced upstream splice acceptor. As a result, the exon becomes circularized (8) (Figure 1b). The second mechanism involves creation of a lariat containing an exon produced from exon skipping. This lariat subsequently undergoes internal splicing, thereby removing the intron and generating a circRNA (28,29) (Figure 1c). Both mechanisms are plausible in vivo, although direct backsplicing is favored as the more frequently used pathway (25). In addition, it cannot be ruled out that multiple mechanisms are involved in exonic circRNA formation. Recent findings indicate that exon circularization is dependent on flanking intronic sequences (30–34). RNA–RNA interactions across flanking introns

Read the complete text